The accumulation of p-tau, Aβ plaques, and presenilin 1 has been shown to increase in both the brains of AD patients (Yu and Wu, 2021) and TMT-induced AD-like phenotypes of rodents (Park et al., 2021). The gene discussed is MAPT; the disease is Alzheimer disease.